External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol
Loading...
Files
Published Version
Date
2017-10-03
Authors
Allotey, John
Snell, Kym I. E.
Chan, Claire
Hooper, Richard
Dodds, Julie
Rogozinska, Ewelina
Khan, Khalid S.
Poston, Lucilla
Kenny, Louise C.
Myers, Jenny
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
Published Version
Abstract
Background: Pre-eclampsia, a condition with raised blood pressure and proteinuria is associated with an increased risk of maternal and offspring mortality and morbidity. Early identification of mothers at risk is needed to target management. Methods/design: We aim to systematically review the existing literature to identify prediction models for pre-eclampsia. We have established the International Prediction of Pregnancy Complication Network (IPPIC), made up of 72 researchers from 21 countries who have carried out relevant primary studies or have access to existing registry databases, and collectively possess data from more than two million patients. We will use the individual participant data (IPD) from these studies to externally validate these existing prediction models and summarise model performance across studies using random-effects meta-analysis for any, late (after 34 weeks) and early (before 34 weeks) onset pre-eclampsia. If none of the models perform well, we will recalibrate (update), or develop and validate new prediction models using the IPD. We will assess the differential accuracy of the models in various settings and subgroups according to the risk status. We will also validate or develop prediction models based on clinical characteristics only; clinical and biochemical markers; clinical and ultrasound parameters; and clinical, biochemical and ultrasound tests. Discussion: Numerous systematic reviews with aggregate data meta-analysis have evaluated various risk factors separately or in combination for predicting pre-eclampsia, but these are affected by many limitations. Our large-scale collaborative IPD approach encourages consensus towards well developed, and validated prognostic models, rather than a number of competing non-validated ones. The large sample size from our IPD will also allow development and validation of multivariable prediction model for the relatively rare outcome of early onset pre-eclampsia. Trial registration: The project was registered on Prospero on the 27 November 2015 with ID: CRD42015029349.
Description
Keywords
Pre-eclampsia , Prognosis , Prediction model , Maternal , Fetal , IPD , |Individual participant data
Citation
Allotey, J., Snell, K. I. E., Chan, C., Hooper, R., Dodds, J., Rogozinska, E., Khan, K. S., Poston, L., Kenny, L., Myers, J., Thilaganathan, B., Chappell, L., Mol, B. W., Von Dadelszen, P., Ahmed, A., Green, M., Poon, L., Khalil, A., Moons, K. G. M., Riley, R. D. and Thangaratinam, S. (2017) 'External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol', Diagnostic and Prognostic Research, 1,16 (13pp). doi: 10.1186/s41512-017-0016-z